Symbiotec Pharmalab IPO Allotment Status

Symbiotec Pharmalab Limited is a book-built mainboard IPO with an issue size of approximately ₹1,757 crore. The offer combines a fresh issue of equity shares worth ₹150 crore with an offer for sale aggregating to ₹1,607 crore. 

The IPO opened for bidding on August 24, 2026, and closes today, August 27, 2026. The basis of allotment is likely on August 28, 2026. Refunds for unsuccessful applicants and credit of equity shares to successful applicants’ demat accounts are expected on August 31, 2026, before the proposed listing on September 1, 2026. 

The issue has a price band of ₹938–₹988 per equity share and a lot size of 15 shares. At the upper price band, retail investors need a minimum investment of ₹14,820 for one lot. 

Investors can check their Symbiotec Pharmalab IPO allotment status after the basis of allotment is finalised through MUFG Intime India, the registrar to the issue, or through the BSE and NSE websites. 

How to Check Symbiotec Pharmalab IPO Allotment Status Online on NSE? 

• Go to the NSE IPO bid verification and application status page.
• Select “Equity & SME IPO bid details.”
• Choose “Symbiotec Pharmalab” under the symbol SYMBIOTEC.
• Enter your PAN and application number.
• Complete the required verification.
• Click on Submit to check the application and allotment status when it becomes available. 

How to Check Symbiotec Pharmalab IPO Allotment Status Online on BSE? 

• Visit the BSE IPO application-status page.
• Select “Equity” under Issue Type.
• Select “Symbiotec Pharmalab Limited” from the Issue Name dropdown.
• Enter your application number or PAN.
• Complete the captcha verification, if requested.
• Click on Search to view the allotment status. 

How to Check Symbiotec Pharmalab IPO Allotment Status on the Registrar’s Website? 

• Visit the official MUFG Intime India IPO allotment-status website.
• Select “Symbiotec Pharmalab Limited” from the available issue-name dropdown after allotment data is uploaded.
• Choose PAN, application number or DP ID/Client ID as the verification method.
• Enter the requested details.
• Complete the captcha verification, where applicable.
• Click on Submit to view your allotment result. 

Symbiotec Pharmalab IPO Details 

Symbiotec Pharmalab’s IPO is priced between ₹938 and ₹988 per equity share. The ₹1,757 crore issue consists of a ₹150 crore fresh issue and a ₹1,607 crore offer for sale. The face value of each equity share is ₹1. 

The public issue opened on August 24, 2026, and closes today, August 27, 2026. The basis of allotment is expected on August 28, 2026, refunds and demat credits are expected on August 31, and the shares are proposed to list on the BSE and NSE on September 1, 2026. 

The minimum retail application comprises one lot of 15 shares, requiring ₹14,820 at the upper price band. Investors may apply in multiples of 15 shares thereafter. 

Allocation Quota for Symbiotec Pharmalab IPO 

Note: The final category-wise allocation can change because of anchor allocation, employee reservations, rounding and other issue-level adjustments. The basis of allotment published by MUFG Intime India will be definitive. 

Symbiotec Pharmalab IPO – Overall Subscription Status 

Symbiotec Pharmalab IPO was subscribed 75.05 times overall as of 4:54 PM of the latest available update. Non-institutional investors so far had subscription of 77.55 times, where as QIBs at 181.20 times, retail investors at 13.64 times and the employee-reserved category at 16.27 times. 

Symbiotec Pharmalab IPO Subscription Details 

(Note: Data is captured as of August 27, 2026, 4:54:57 PM) 

Total Applications received so far: 52,73,654 

Final subscription figures may differ slightly after exchange reconciliation and reporting cut-off adjustments. 

Read More: IPO Alert: Ananya Birla's Svatantra Microfin Files Draft Papers with SEBI to Raise Funds! 

Symbiotec Pharmalab Business Overview 

Symbiotec Pharmalab is a Madhya Pradesh-based contract development and manufacturing organisation, or CDMO, operating in the pharmaceutical sector. The company manufactures and develops active pharmaceutical ingredients and related pharmaceutical products for customers across markets. 

The net proceeds from the fresh issue are intended to support the company’s growth and corporate requirements. Proceeds from the offer for sale will go to the selling shareholders and will not be received by the company. 

Symbiotec Pharmalab IPO allotment status is expected to be available on August 28, 2026, after the basis of allotment is approved. Investors can check through MUFG Intime India, BSE or NSE using their PAN, application number or DP ID/Client ID. 

Know more about IPO allotment status and check your application details online for the latest updates on share allocation. 

Disclaimer: This article has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute personal investment advice or a recommendation to buy, sell or hold any security. Investors should conduct their own research and consult a SEBI-registered investment adviser before making investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.